Loading research…
Haemonetics Corporation (NYSE: HAE)
Haemonetics Corporation trades on NYSE under the symbol HAE, quoted in USD. The listing is associated with United States. Its sector is Health technology, within Medical specialties. Reported figures retain their financial periods. Market prices and charts are shown separately from dated research.
- Exchange
- NYSE
- Country
- United States
- Sector
- Health technology
- Industry
- Medical specialties
- Trading currency
- USD
- ISIN
- US4050241003
Reported financials
Research date October 28, 2026. Figures below are dated observations, not market quotes.
| Metric | Value | Period | Period end |
|---|---|---|---|
| Revenue | 1,352,013,000.00 USD | TTM | Jun 30, 2026 |
| Net income | 96,287,000.00 USD | TTM | Jun 30, 2026 |
| Diluted EPS | 2.05 USD | TTM | Jun 30, 2026 |
| Total assets | 2,395,925,000.00 USD | Annual | Mar 31, 2026 |
| Total debt | 1,274,721,000.00 USD | Annual | Mar 31, 2026 |
| Gross margin | 55.91% | TTM | Jun 30, 2026 |
| Operating margin | 18.37% | TTM | Jun 30, 2026 |
| Return on equity | 11.20% | TTM | Jun 30, 2026 |
| Return on assets | 3.99% | TTM | Jun 30, 2026 |
| Dividend per share | 0.00 USD | Annual | Mar 31, 2026 |
Stock ScreenerEarnings CalendarDividends CalendarStock investing guide
Data notes
Scores, valuation models and research metrics use dated FOLITIC research. Dates and currencies remain attached to their observations. Missing values are shown as a dash.
Market quotes and charts use the separate market-data display. Saved research prices and model comparisons are not live quotes. Model ranges represent sensitivity scenarios, not confidence intervals or price guarantees.
Listings on different exchanges and different share classes are kept separate. No currency conversion is applied to saved research values.